Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
3billion | RCV000001560 | SCV002058585 | pathogenic | Autosomal recessive nonsyndromic hearing loss 28 | 2022-01-03 | criteria provided, single submitter | clinical testing | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS).The variant has been reported to be associated with TRIOBP related disorder (ClinVar ID: VCV000001495, PMID:16385457). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000032, PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Gene |
RCV002460876 | SCV002756581 | pathogenic | not provided | 2022-05-16 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 34868251, 27014650, 29197352, 16385457) |
Fulgent Genetics, |
RCV000001560 | SCV002813834 | pathogenic | Autosomal recessive nonsyndromic hearing loss 28 | 2021-12-12 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000001560 | SCV000021715 | pathogenic | Autosomal recessive nonsyndromic hearing loss 28 | 2006-01-01 | no assertion criteria provided | literature only |